Adults with rapid onset knee osteoarthritis that occurs and progressess within as little as four years, are more likely to receive pharmacological treatments or even surgery than those who live with the condition long-term.
Adults with rapid onset knee osteoarthritis that occurs and progressess within as little as four years, are more likely to receive pharmacological treatments or even surgery than those who live with the condition long-term, according to a brief report published last month in ACR Open Rheumatology.
"Those with accelerated knee osteoarthritis utilized treatment options and health care resources far more often than adults who developed typical knee osteoarthritis, likely because they quickly developed advancedâstaged disease," wrote authors who were led by Jeffrey Driban, Ph.D., of Tufts Medical Center, Boston.
This was an 8-year long study that included participants with no radiographic knee osteoarthritis at baseline. The study group was broken down into three groups: one with advanced stage knee osteoarthritis that advanced in severity within four years or less; a second group with typical knee osteoarthritis that increased in severity over eight years; and, a third group with no knee osteoarthritis and no change over eight years.
Adults who developed accelerated knee osteoarthritis, also known as rapid onset knee osteoarthritis, were more likely to report having had arthroscopic knee surgery than the knee osteoarthritis group (32 percent vs 8 percent) and have other treatments, such as hyaluronic acid injections (10 and 4 percent, respectively); intra-articular corticosteroid injections (30 and 7 percent, respectively); NSAID use (65 and 48 percent, respectively); and, prescription pain medicatio (61 and 43 percent, respectively).
Julie E. Davis BS Matthew S. Harkey PhD, ATC ShaoâHsien Liu PhD, et al. "Adults With Incident Accelerated Knee Osteoarthritis Are More Likely to Use Pharmacological Treatment Options and Receive Arthroscopic Knee Surgery: Data From the Osteoarthritis Initiative," ACR Open Rheumatology. First published: 25 July 2019 https://doi.org/10.1002/acr2.11058